Torasemide
From Wikipedia, the free encyclopedia
(Redirected from Torsemide)
Torasemide
Systematic (IUPAC) name
1-[4-(3-methylphenyl) aminopyridin-3-yl] sulfonyl-3-propan-2-yl-urea
Identifiers
Chemical data
Mol. mass 348.421 g/mol
SMILES &
Pharmacokinetic data
Bioavailability 80-90%
Protein binding Highly bound (>99%).
Metabolism Hepatic (80%)
Therapeutic considerations
Pregnancy cat.
C(US)
Torasemide (rINN) or torsemide (USAN) is a pyridine-sulfonylurea type loop diuretic mainly used in the management of edema associated with congestive heart failure. It is also used at low doses for the management of hypertension. It is marketed under the brand name Demadex.
Compared to other loop diuretics, torasemide has a more prolonged diuretic effect than equipotent doses of furosemide and relatively decreased potassium-loss. There is no evidence of torasemide-induced ototoxicity demonstrated in humans [1].
[edit] References
^ Dunn CJ, Fitton A, Brogden RN (January 1995). "Torasemide. An update of its pharmacological properties and therapeutic efficacy". Drugs 49 (1): 121–42. PMID 7705212.
[edit] External links
Medlineplus drug information: Torsemide (Systemic) – information from USP DI Advice for the Patient
This pharmacology-related article is a stub. You can help Wikipedia by expanding it.
